Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Shengnan Bao"'
Autor:
Xueqi Yan, Yaozhou He, Shikun Yang, Tianyu Zeng, Yijia Hua, Shengnan Bao, Fan Yang, Ningjun Duan, Chunxiao Sun, Yan Liang, Ziyi Fu, Xiang Huang, Wei Li, Yongmei Yin
Publikováno v:
Cell Death Discovery, Vol 8, Iss 1, Pp 1-13 (2022)
Abstract As a key regulator of the DNA translesion synthesis (TLS) pathway, RAD18 is error-prone and contributes to the accumulation of DNA mutations. Our previous study showed that it plays an essential role in the progression of multiple tumors. Ho
Externí odkaz:
https://doaj.org/article/f56cd22b7d2d46d5a0dddd78fd5d7001
Autor:
Shengnan Bao, Mengping Jiang, Xi Wang, Yijia Hua, Tianyu Zeng, Yiqi Yang, Fan Yang, Xueqi Yan, Chunxiao Sun, Mengzhu Yang, Ziyi Fu, Xiang Huang, Jun Li, Hao Wu, Wei Li, Jinhai Tang, Yongmei Yin
Publikováno v:
Cancer Medicine, Vol 10, Iss 23, Pp 8662-8672 (2021)
Abstract Background With life span extending, breast cancer (BC) survivors may face the possibility of developing second primary cancer (SPC) and considerably shorten survivorship. However, little is known about multiple primary cancer (MPC) patients
Externí odkaz:
https://doaj.org/article/a0dcf298c0364db1a979aba0ed63fa50
Autor:
Mengping Jiang, Xiangyan Wu, Shengnan Bao, Xi Wang, Fei Qu, Qian Liu, Xiang Huang, Wei Li, Jinhai Tang, Yongmei Yin
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
TP53, a gene with high-frequency mutations, plays an important role in breast cancer (BC) development through metabolic regulation, but the relationship between TP53 mutation and metabolism in BC remains to be explored. Our study included 1,066 BC sa
Externí odkaz:
https://doaj.org/article/7466bb37ec1143078e12ab3b0d8b0c66
Publikováno v:
Ecotoxicology and Environmental Safety, Vol 233, Iss , Pp 113326- (2022)
Fungi have a promising application prospect in the remediation of heavy-metal wastewater pollution which is a sticky global problem. New marine-derived strain Penicillium janthinellum P1 is of high chromium resistance. However, a comprehensive study
Externí odkaz:
https://doaj.org/article/b9c0f18a74bd4dd59f89c9280339d710
Autor:
Shengnan Bao, Yi Chen, Fan Yang, Chunxiao Sun, Mengzhu Yang, Wei Li, Xiang Huang, Jun Li, Hao Wu, Yongmei Yin
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Lapatinib, targeting the human epidermal growth factor receptor family members HER1 and HER2, has been approved by the US Food and Drug Administration for use in metastatic HER2-positive breast cancer. However, resistance to lapatinib remains a commo
Externí odkaz:
https://doaj.org/article/3909a963d57342479c0ea39c1ebc9045
Autor:
Mengzhu Yang, Yiqi Yang, Mengping Jiang, Ziyi Fu, Jinhai Tang, Tianyu Zeng, Xueqi Yan, Chunxiao Sun, Yijia Hua, Fan Yang, Wei Li, Xiang Huang, Yongmei Yin, Shengnan Bao, Xi Wang, Hao Wu, Jun Li
Publikováno v:
Cancer Medicine, Vol 10, Iss 23, Pp 8662-8672 (2021)
Cancer Medicine
Cancer Medicine
Background With life span extending, breast cancer (BC) survivors may face the possibility of developing second primary cancer (SPC) and considerably shorten survivorship. However, little is known about multiple primary cancer (MPC) patients with non
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d52fb60c6bc470cc44edd3f90c881bda
https://doi.org/10.1002/cam4.4351
https://doi.org/10.1002/cam4.4351
Autor:
Tianyu Zeng, Chunxiao Sun, Yan Liang, Fan Yang, Xueqi Yan, Shengnan Bao, Yucheng Zhang, Xiang Huang, Ziyi Fu, Wei Li, Yongmei Yin
Publikováno v:
Cancers; Volume 14; Issue 17; Pages: 4084
Treatment options for human epidermal growth factor receptor (HER2)-negative breast cancer patients are limited in comparison to the HER2-positive patients, particularly for metastatic breast cancer patients. Apatinib is a small-molecule tyrosine kin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15b44d78a735b3cfacd0a6f0a7c85ee3
https://pubmed.ncbi.nlm.nih.gov/36077621
https://pubmed.ncbi.nlm.nih.gov/36077621
Publikováno v:
The Breast Journal.
Purpose. This study explored the effects of recent childbirth and recent breastfeeding on the risk of recurrence in patients with postpartum breast cancer (PPBC). Materials and Methods. A bidirectional cohort study was conducted in the First Affiliat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a31ed79a8b1e17a6e6076323a2b445f7
Autor:
Xueqi Yan, Yincheng Liu, Ziyi Fu, Tianyu Zeng, Jun Li, Hai Xu, Shengnan Bao, Yaozhou He, Xiang Huang, Mengping Jiang, Yan Liang, Mengzhu Yang, Fan Yang, Yiqi Yang, Chunxiao Sun, Wei Li, Yijia Hua, Yongmei Yin, Xi Wang
Background With increased survival in breast cancer, resulting from advances in treatment, patients incur the possibility of subsequent primary malignancies, especially lung cancer. The aim of this study was to assess the frequency of CT-detected pul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c347d84c4a86af11fb00b68444899b6a
https://doi.org/10.21203/rs.3.rs-763128/v1
https://doi.org/10.21203/rs.3.rs-763128/v1
Autor:
Yongmei Yin, Chunxiao Sun, Yijia Hua, Mengping Jiang, Fan Yang, Xinyu Wu, Tianyu Zeng, Shengnan Bao, Yan Liang, Xiang Huang, Wei Li
Publikováno v:
Journal of Clinical Oncology. 40:e13029-e13029
e13029 Background: Trastuzumab emtansine (T-DM1) has shown great effectiveness in treating HER2-positive metastatic breast cancer, but therapies subsequent to T-DM1 progression are still controversial. Here, we investigated efficacy and safety of tyr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd94b3014dc58cd655359d4e4e336f02
https://doi.org/10.1200/jco.2022.40.16_suppl.e13029
https://doi.org/10.1200/jco.2022.40.16_suppl.e13029